Cacace Angela M 4
4 · ARVINAS, INC. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Arvinas (ARVN) CSO Angela Cacace Sells 2,576 Shares
What Happened
Angela M. Cacace, Chief Scientific Officer of Arvinas, sold 2,576 shares on June 17, 2026 at $7.59 per share, resulting in proceeds of $19,565. This transaction is recorded as a sale and does not indicate a discretionary buy or sell decision.
Key Details
- Transaction date and price: 2026-06-17 at $7.59 per share.
- Total proceeds: $19,565.
- Shares owned after the transaction: Not specified in the provided filing.
- Footnote: The sale was automatic to cover tax withholding related to the vesting and settlement of one-half of RSUs granted on June 17, 2024, executed pursuant to a durable sale instruction (not a discretionary trade).
- Filing date: Form 4 filed 2026-06-18 — appears timely.
Context
This was a tax-withholding sale tied to RSU vesting (common practice when companies remit taxes by selling a portion of vested shares). Such transactions are routine and typically do not signal the insider’s discretionary view on the company’s stock.
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Cacace Angela M
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1]2026-06-17$7.59/sh−2,576$19,565→ 180,390 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on June 17, 2024 pursuant to a durable sale instruction. The sale does not represent a discretionary trade.
Signature
/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace|2026-06-18